Heil Emily L, Bork Jacqueline T, Abbo Lilian M, Barlam Tamar F, Cosgrove Sara E, Davis Angelina, Ha David R, Jenkins Timothy C, Kaye Keith S, Lewis James S, Ortwine Jessica K, Pogue Jason M, Spivak Emily S, Stevens Michael P, Vaezi Liza, Tamma Pranita D
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Open Forum Infect Dis. 2021 Oct 11;8(10):ofab434. doi: 10.1093/ofid/ofab434. eCollection 2021 Oct.
Guidance on the recommended durations of antibiotic therapy, the use of oral antibiotic therapy, and the need for repeat blood cultures remain incomplete for gram-negative bloodstream infections. We convened a panel of infectious diseases specialists to develop a consensus definition of uncomplicated gram-negative bloodstream infections to assist clinicians with management decisions.
Panelists, who were all blinded to the identity of other members of the panel, used a modified Delphi technique to develop a list of statements describing preferred management approaches for uncomplicated gram-negative bloodstream infections. Panelists provided level of agreement and feedback on consensus statements generated and refined them from the first round of open-ended questions through 3 subsequent rounds.
Thirteen infectious diseases specialists (7 physicians and 6 pharmacists) from across the United States participated in the consensus process. A definition of uncomplicated gram-negative bloodstream infection was developed. Considerations cited by panelists in determining if a bloodstream infection was uncomplicated included host immune status, response to therapy, organism identified, source of the bacteremia, and source control measures. For patients meeting this definition, panelists largely agreed that a duration of therapy of ~7 days, transitioning to oral antibiotic therapy, and forgoing repeat blood cultures, was reasonable.
In the absence of professional guidelines for the management of uncomplicated gram-negative bloodstream infections, the consensus statements developed by a panel of infectious diseases specialists can provide guidance to practitioners for a common clinical scenario.
关于革兰氏阴性菌血流感染的抗生素治疗推荐疗程、口服抗生素治疗的使用以及重复血培养的必要性,相关指导意见仍不完整。我们召集了一组传染病专家,以制定非复杂性革兰氏阴性菌血流感染的共识定义,以协助临床医生进行管理决策。
小组成员均对其他成员的身份不知情,他们采用改良的德尔菲技术,制定了一系列描述非复杂性革兰氏阴性菌血流感染首选管理方法的陈述。小组成员对生成的共识陈述提供了同意程度和反馈,并从第一轮开放式问题开始,经过随后三轮对这些陈述进行完善。
来自美国各地的13名传染病专家(7名医生和6名药剂师)参与了共识制定过程。制定了非复杂性革兰氏阴性菌血流感染的定义。小组成员在确定血流感染是否为非复杂性时考虑的因素包括宿主免疫状态、对治疗的反应、鉴定出的病原体、菌血症的来源以及源头控制措施。对于符合该定义的患者,小组成员在很大程度上一致认为,约7天的治疗疗程、过渡到口服抗生素治疗以及不进行重复血培养是合理的。
在缺乏非复杂性革兰氏阴性菌血流感染管理专业指南的情况下,一组传染病专家制定的共识陈述可为从业者处理常见临床情况提供指导。